<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01639053</url>
  </required_header>
  <id_info>
    <org_study_id>CP-1007</org_study_id>
    <nct_id>NCT01639053</nct_id>
  </id_info>
  <brief_title>Sientra Post-Approval Study</brief_title>
  <official_title>U.S. Postapproval Study of Sientra Silicone Gel Breast Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sientra, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sientra, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a ten-year postapproval study to evaluate the long-term clinical performance of
      Sientra Silicone Gel Breast Implants under general conditions of use in the postmarket
      environment.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term safety of Sientra Silicone Gel Breast Implants in women</measure>
    <time_frame>10-years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Breast Augmentation</condition>
  <condition>Breast Reconstruction</condition>
  <condition>Breast Revision</condition>
  <arm_group>
    <arm_group_label>Gel Participants</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Participants</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women who receive Sientra Silicone Gel Breast Implants for augmentation, revision
        augmentation, reconstruction, and revision reconstruction. Control participants are
        candidates for and undergo aesthetic surgery other than implantation with Silicone Gel
        Breast implants.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Genetic female with US residency

          2. Is at least 18 years old for primary or revision reconstruction or 22 years old for
             primary or revision augmentation

          3. Agrees to Sientra study requirements

        Exclusion Criteria:

          1. Has an active infection anywhere in body

          2. Has active cancer without adequate treatment

          3. Currently pregnant or nursing

          4. Has any condition or diagnosis that, in the investigator's opinion, would negatively
             affect ability to complete study requirements

          5. If control participant, has undergone breast implant surgery with silicone gel-filled
             breast implants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sientra, Inc.</last_name>
    <role>Study Director</role>
    <affiliation>Sponsor GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sientra, Inc.</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2012</study_first_submitted>
  <study_first_submitted_qc>July 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2012</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Augmentation</keyword>
  <keyword>Breast Reconstruction</keyword>
  <keyword>Breast Revision</keyword>
  <keyword>Silicone breast implants</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

